CClinicalTrials.gg
CompletedNCT01912248Updated Jan 27, 2015

Acute Effect of Strength Training on Blood Pressure in Cardiac Patients

An observational study in Heart Failure, Ischemic Heart Disease and Heart Transplant Recipients, sponsored by Christian Dall. Completed at 1 site in Denmark. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-01-27.

Sponsored by Christian Dall · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
36
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Moderate and heavy strength training exercise and the acute blood pressure rise in cardiac patient, how high?

Read the detailed description

12 heart transplant recipients 12 heart failure patients 12 patients with ischemic heart disease

02

Conditions studied

  • Heart Failure
  • Ischemic Heart Disease
  • Heart Transplant Recipients

Keywords

  • acute rise of systolic and diastolic bloodpressure
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 36 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

This is the only study on the registry with Christian Dall as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

12 heart transplant recipients 12 heart failure patients 12 patients with ischemic disease

Inclusion criteria

  • 18 years
  • no strength training > 3 month
  • speak and understand danish

Exclusion criteria

Exclusion Criteria:

  • cancer
  • serum creatinin above 200 mmol/l
  • re-transplantation
  • Ejection fraction > 35
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
36 participants (actual)
Patient registry
No

Groups and cohorts

  • Heart failure

    strength training

    Other: strength training

  • Heart Transplant recipients

    strength training

    Other: strength training

  • patients with ischemic heart disease

    strength training

    Other: strength training

Interventions

  • Otherstrength training

    strength training, lower limb.

    Also known as: one hour of strength training.

06

What researchers measure

Primary outcomes

  1. systolic blood pressure

    Time frame: one test, 1 hour, continuated systolic blood pressure surveliance

Secondary outcomes

  1. diastolic blood pressure

    Time frame: one test 1 hour, continuated bloodpressure surveliance

07

Study locations

1 site
  • Christian Dall
    Copenhagen, 2400, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01912248
Lead sponsor
Christian Dall
Responsible party
Christian Dall (cand.scient, Bispebjerg Hospital) — Sponsor-investigator
First posted
Jul 31, 2013
Start date
Jul 2013
Primary completion
Apr 2014
Completion
Apr 2014
Last update
Jan 27, 2015

Study contacts

Christian H Dall, cand.scient
principal investigator · Bispebjerg Hospital, Denmark

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion